Changes in Platelet Indices during Pregnancy as Potential Markers for Prediction of Preeclampsia Development


Objective: To assess whether changes in platelet indices, detectable by simple complete blood count (CBC), during pregnancy could be used as markers for prediction of development of preeclampsia (PE). Methods: A total of 2813 pregnant women who received regular antenatal care until delivery were included. Participants were divided into 3 groups: normotensive pregnant women (n = 2621), women with PE without severe features (n = 169), and women with PE with severe features (n = 23). Blood samples were collected during antenatal visits and/or during the period of in-patient hospital stay, and changes in platelet indices were compared among the three groups. Results: Platelet count (PC) was decreasing while mean platelet volume (MPV) and platelet distribution width (PDW) were increasing as PE progressed. Receiver operating characteristics (ROC) curve analysis showed that PDW had the largest area under curve (AUC) [0.980 (95% CI: 0.964 - 1.000)], making it the best marker for predicting development of PE. Also, PDW showed the most statistically significant correlation with mean arterial pressure (MAP) (r = 0.902, p = 0.000), making it the best marker for predicting severity of hypertension. Conclusion: This study provides evidence that PC decreases while MPV and PDW increase as pregnancy advances, and these changes are more pronounced in PE than normotensive pregnancy. These changes predate development of PE by 2 - 8 weeks and are proportional to the progress of this disorder. The selected platelet indices, especially PDW, have the potential to be utilized as markers for not only prediction of PE development but also severity of hypertension.

Share and Cite:

Nooh, A. and Abdeldayem, H. (2015) Changes in Platelet Indices during Pregnancy as Potential Markers for Prediction of Preeclampsia Development. Open Journal of Obstetrics and Gynecology, 5, 703-712. doi: 10.4236/ojog.2015.512099.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Ananth, C.V., Keyes, K.M. and Wapner, R.J. (2013) Preeclampsia Rates in the United States, 1980-2010: Age-Period-Cohort Analysis. BMJ, 347, f6564.
[2] (2000) Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. American Journal of Obstetrics and Gynecology, 183, S1-S22.
[3] Ness, R.B. and Sibai, B.M. (2006) Shared and Disparate Components of the Pathophysiologies of Fetal Growth Restriction and Preeclampsia. American Journal of Obstetrics and Gynecology, 195, 40-49.
[4] Sibai, B.M. (2011) Evaluation and Management of Severe Preeclampsia before 34 Weeks’ Gestation. American Journal of Obstetrics and Gynecology, 205, 191-198.
[5] Sibai, B.M., Dekker, G. and Kupferminc, M. (2005) Preeclampsia. The Lancet, 365, 785-799.
[6] (2013) Report of the ACOG Task Force on Hypertension in Pregnancy. Hypertension in Pregnancy. Obstetrics & Gynecology, 122, 1122-1131.
[7] Bujold, E., Roberge, S., Lacasse, Y., et al. (2010) Prevention of Preeclampsia and Intrauterine Growth Restriction with Aspirin Started in Early Pregnancy: A Meta-Analysis. Obstetrics & Gynecology, 116, 402-414.
[8] Sibai, B.M. (2003) Diagnosis and Management of Gestational Hypertension and Preeclampsia. Obstetrics & Gynecology, 102, 181-192.
[9] Yang, S.W., Cho, S.H., Kwon, H.S., et al. (2014) Significance of the Platelet Distribution Width as a Severity Marker for the Development of Preeclampsia. European Journal of Obstetrics & Gynecology and Reproductive Biology, 175, 107-111.
[10] Scazzocchio, E., Figueras, F., Crispi, F., et al. (2013) Performance of a First-Rimester Screening of Preeclampsia in a Routine Care Low-Risk Setting. American Journal of Obstetrics and Gynecology, 208, 203.e1-203.e10.
[11] Akolekar, R., Syngelaki, A., Sarquis, R., et al. (2011) Prediction of Early, Intermediate and Late Preeclampsia from Maternal Factors, Biophysical and Biochemical Markers at 11-13 Weeks. Prenatal Diagnosis, 31, 66-74.
[12] Scazzocchio, E. and Figueras, F. (2011) Contemporary Prediction of Preeclampsia. Current Opinion in Obstetrics and Gynecology, 23, 65-71.
[13] Dundar, O., Yoruk, P., Tutuncu, L., et al. (2008) Longitudinal Study of Platelet Size Changes in Gestation and Predictive Power of Elevated MPV in Development of Preeclampsia. Prenatal Diagnosis, 28, 1052-1056.
[14] Jaremo, P., Lindahl, T.L., Lennmarken, C., et al. (2000) The Use of Platelet Density and Volume Measurements to Estimate the Severity of Preeclampsia. European Journal of Clinical Investigation, 30, 1113-1118.
[15] Ceyhan, T., Beyan, C., Baser, I., et al. (2006) The Effect of Preeclampsia on Complete Blood Count, Platelet Count and Mean Platelet Volume. Annals of Hematology, 85, 320-322.
[16] Vagdatli, E., Gounari, E., Lazaridou, E., et al. (2010) Platelet Distribution Width: A Simple, Practical and Specific Marker of Activation of Coagulation. Hippokratia, 14, 28-32.
[17] Brown, M.A., Lindheimer, M.D., de Swiet, M., et al. (2001) The Classification and Diagnosis of the Hypertensive Disorders of Pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertension in Pregnancy, 20, 9-14.
[18] Martinez, E.Z., Louzada-Neto, F. and Pereira, B.B. (2003) A curva ROC para testes diagnósticos. Cadernos Saúde Coletiva, 11, 7-31.
[19] Simeone, S., Lojo, C., Garcia-Esteve, L., et al. (2015) Psychological Impact of First-Trimester Prevention for Preeclampsia on Anxiety. Prenatal Diagnosis, 35, 60-64.
[20] Trogstad, L., Magnus, P. and Stoltenberg, C. (2011) Preeclampsia: Risk Factors and Causal Models. Best Practice & Research Clinical Obstetrics & Gynaecology, 30, 1-14.
[21] Hernandez-Diaz, S., Toh, S. and Cnattingius, S. (2009) Risk of Preeclampsia in First and Subsequent Pregnancies: Prospective Cohort Study. BMJ, 338, b2255.
[22] McDonald, S.D., Malinowski, A., Zhou, Q., et al. (2008) Cardio-Vascular Sequelae of Preeclampsia/Eclampsia: A Systematic Review and Meta-Analyses. American Heart Journal, 156, 918-930.
[23] Roberts, J.M. and Cooper, D.W. (2001) Pathogenesis and Genetics of Preeclampsia. The Lancet, 357, 53-56.
[24] Tanaka, M., Jaamaa, G., Kaiser, M., et al. (2007) Racial Disparity in Hypertensive Disorders of Pregnancy in New York State: A 10-Year Longitudinal Population-Based Study. American Journal of Public Health, 97, 163-170.
[25] Ananth, C.V. and Basso, O. (2010) Impact of Pregnancy-Induced Hypertension on Stillbirth and Neonatal Mortality. Epidemiology, 21, 118-123.
[26] Goldenberg, R.L., Culhane, J.F., Iams, J.D., et al. (2008) Epidemiology and Causes of Preterm Birth. The Lancet, 371, 75-84.
[27] Zhang, J., Troendle, J.F. and Levine, R.J. (2001) Risks of Hypertensive Disorders in the Second Pregnancy. Paediatric and Perinatal Epidemiology, 15, 226-231.
[28] Conde-Agudelo, A., Belizan, J.M. and Diaz-Rossello, J.L. (2000) Epidemiology of Fetal Death in Latin America. Acta Obstetricia et Gynecologica Scandinavica, 79, 371-378.
[29] Ray, J.G., Vermeulen, M.J., Schull, M.J., et al. (2005) Cardiovascular Health after Maternal Placental Syndromes (CHAMPS): Population-Based Retrospective Cohort Study. The Lancet, 366, 1797-1803.
[30] Irgens, H.U., Reisaeter, L., Irgens, L.M., et al. (2001) Long Term Mortality of Mothers and Fathers after Preeclampsia: Population Based Cohort Study. BMJ, 323, 1213-1217.
[31] Guzin, K., Tomruk, S., Tuncay, Y.A., et al. (2005) The Relation of Increased Uterine Artery Blood Flow Resistance and Impaired Trophoblast Invasion in Pre-Eclamptic Pregnancies. Archives of Gynecology and Obstetrics, 272, 283-288.
[32] Kuscu, N.K., Kurhan, Z., Yildirim, Y., et al. (2003) Detection of Endothelial Dysfunction in Preeclamptic Patients by Using Colour Doppler Sonography. Archives of Gynecology and Obstetrics, 268, 113-116.
[33] Missfelder-Lobos, H., Teran, E., Lees, C., et al. (2002) Platelet Changes and Subsequent Development of Preeclampsia and Fetal Growth Restriction in Women with Abnormal Uterine Artery Doppler Screening. Ultrasound in Obstetrics and Gynecology, 19, 443-448.
[34] Vijaya, C., Lekha, M.B., Shetty, A., et al. (2014) Evaluation of Platelet Counts and Platelet Indices and Their Significant Role in Preeclampsia and Eclampsia. Journal of Evolution of Medical and Dental Sciences, 3, 3216-3219.
[35] Freitas, L.G., Alpoim, P.N., Komatsuzaki, F., et al. (2013) Preeclampsia: Are Platelet Count and Indices Useful for Its Prognostic? Hematology, 18, 360-364.
[36] Dadhich, S., Agrawal, S., Soni, M., et al. (2012) Predictive Value of Platelet Indices in Development of Preeclampsia. Journal of SAFOG with DVD, 4, 17-21.
[37] Gioia, S., Piazze, J., Anceschi, M.M., et al. (2007) Mean Platelet Volume: Association with Adverse Neonatal Outcome. Platelets, 18, 284-288.
[38] Makuyana, D., Mahomed, K., Shukusho, F.D., et al. (2002) Liver and Kidney Function Tests in Normal and Pre-Eclamptic Gestation—A Comparison with Non-Gestational Reference Values. Central African Journal of Medicine, 48, 55-59.

Copyright © 2021 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.